UNSPSC 51171526: Troxipide

This classification denotes a piperidine with the molecular formula C15H22N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W6QJX1Q00Z, chemically known as 3,4,5-trimethoxy-n-(3-piperidyl)benzamide but generally known as troxipide, which bears US NIH Compound Identifier 5597. European Medicines Agency schedules Troxipide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11353MIG. World Health Organization schedules troxipide in its Anatomical Therapeutic Chemical (ATC) Classification.

TROXIPIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule troxipide under HS 29333999 and SITC 51574. As of Q4 2014, TROXIPIDE remains the US FDA Preferred Term for this commodity. SMILES: O=C(NC1CCCNC1)C1CC(OC)C(OC)C(OC)C1.

UNSPSC 51171526 Troxipide is a Commodity code with no recent state and local procurement activity aligned to its nominal pharmaceutical scope. The single opportunity posted under this code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—represents a clear classification mismatch; the solicitation calls for drug testing laboratory operations, specimen handling, and immunoassay/confirmatory testing infrastructure, not troxipide procurement or distribution. The work involves staffing two collection sites in Texas, operating an Interactive Voice Response system for randomized testing notifications, conducting screening and confirmation testing (five-panel, six-panel, and ancillary panels) via immunoassay with LC/MS/MS or GC/MS confirmation, and offering alternative testing modalities including oral fluid and hair testing—activities that fall outside pharmaceutical product sourcing.

Collin County's RFP 2026-327 carried a July 23, 2026 response deadline and an estimated contract value of $600,000 over two years with three optional one-year renewals, not to exceed five years total. The county sought a SAMHSA-, TX DPS-, or CAP-certified laboratory operator capable of managing approximately 25,031 annual tests across multiple panel configurations. Pricing was required on a per-test basis across three service models (screening only, confirmation after screening, and automatic confirmation of positives), with all costs to include staffing, freight, delivery, and insurance; price redetermination requests were limited to annual September 1 effective dates with increases capped at 3.0 percent based on medical Consumer Price Index adjustments. Evaluation weighted vendor understanding and qualifications (55 points combined), client references (15 points), cost (30 points), and optional demonstrations or interviews (up to 30 points). The anticipated award date was August 10, 2026. This code shows minimal relevant recent state and local procurement activity.